Patents by Inventor Julie Lynne Christensen

Julie Lynne Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
    Publication number: 20220064600
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Application
    Filed: October 12, 2021
    Publication date: March 3, 2022
    Inventors: Timothy C. FONG, Adrianus Geertrudis Wilhelmus DOMEN, Julie Lynne CHRISTENSEN
  • METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
    Publication number: 20190241872
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Application
    Filed: February 11, 2019
    Publication date: August 8, 2019
    Applicant: CELLERANT THERAPEUTICS, INC.
    Inventors: TIMOTHY C. FONG, ADRIANUS GEERTRUDIS WILHELMUS DOMEN, JULIE LYNNE CHRISTENSEN
  • Methods of expanding myeloid cell populations and uses thereof
    Patent number: 10260044
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: April 16, 2019
    Assignee: CELLERANT THERAPEUTIC, INC.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
    Publication number: 20190106680
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Application
    Filed: October 9, 2018
    Publication date: April 11, 2019
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • Methods of expanding myeloid cell populations and uses thereof
    Patent number: 8877495
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: November 4, 2014
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • Methods of expanding myeloid cell populations and uses thereof
    Patent number: 8481315
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: July 9, 2013
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
    Publication number: 20130089527
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Application
    Filed: September 24, 2012
    Publication date: April 11, 2013
    Applicant: Cellerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • Methods and compositions for enhancing engraftment of hematopoietic stem cells
    Patent number: 8383095
    Abstract: The present disclosure relates to the field of hematopoietic stem cell transplantation. More specifically, methods, compositions and kits for improving engraftment of stem cell transplants by administering myeloid progenitor cells are provided.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: February 26, 2013
    Assignee: Cellerant Therapeutics, Inc.
    Inventors: Julie Lynne Christensen, Holger Karsunky
  • METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
    Publication number: 20130004468
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Application
    Filed: July 2, 2012
    Publication date: January 3, 2013
    Applicant: Cellerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen
  • Methods of expanding myeloid cell populations and uses thereof
    Patent number: 8252587
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: August 28, 2012
    Assignee: Celerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen